EUCTR2009-014690-41-FRActive, not recruitingNot Applicable
Comparison of the protective effect of two cardioplegic solutions Custodiol versus St Thomas on the cardiac metabolism assessed by microdialysis in coronary surgery
CHU de Saint-Etienne0 sitesStarted: August 6, 2009Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •- aged over 18 years
- •- referred for Cardiovascular Surgery indicating coronary revascularization surgery
- •- consent form signed
- •- social security regimen affiliated
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •- Patients with an indication of beating-heart surgery
- •- Emergency surgery and patients with myocardial infarction less than a week before the surgery
- •- Surgery iterative
Investigators
Similar Trials
Completed
Unknown
The comparison of cardiac rehabilitation protocols (functional and ordinary) on atherosclerosis biomarkers and functional capacity in coronary arteries patientsCoronary artery disease.Atherosclerotic heart disease of native coronary arteryI25.1IRCT20231111060023N1Allameh Tabataba'i University30
Unknown
Phase 4
A Comparison of Two Anaesthetic Methods of Protecting Heart Tissue During Cardiac SurgeryCoronary Artery Bypass SurgeryNCT00244283Golden Jubilee National Hospital150
Completed
Not Applicable
Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass GraftCoronary Artery Bypass GraftDexmedetomidineLidocaineMyocardial InjuryBlood Electrolyte BalanceArrhythmiaUnstable AnginaNCT01688648Samsung Medical Center160
Not yet recruiting
Phase 2
Comparison between two heart immobilising agents in patients undergoing heart surgery.CTRI/2024/03/064618Head of the Department Department of Cardiac Anesthesiology
Completed
Not Applicable
Efficacy of intracoronary abciximab in percutaneous coronary interventioST-segment elevation myocardial infarction.myocardial infarction specified as acute or with a stated duration of 4 weeks (28 days) or less from onsetIRCT2012081310573N1Cardiovascular Research Center, Shahid Beheshti University of Medical sciences40